RPL31

Large ribosomal subunit protein eL31 · P62899 · RPL31 on Sugi Atlas →

0 patent compounds predicted against RPL31, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL31 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE3COMPLETED
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1WITHDRAWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) nanACTIVE_NOT_RECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Proteomics and Orthodontic Root Resorption nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis nanNOT_YET_RECRUITING
Quantification of GADD34 Expression in RA nanCOMPLETED
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RPL31 binder may also engage these)

ProteinNameSimilarity
Q56JX3 1.000 Q56JX3 →
G1SHG0 1.000 G1SHG0 →
Q90YT7 1.000 Q90YT7 →
P62902 1.000 P62902 →
P62900 1.000 P62900 →
P62901 1.000 P62901 →
Q1KSC7 1.000 Q1KSC7 →
Q5RBR9 1.000 Q5RBR9 →
Q9IA76 1.000 Q9IA76 →
Q6NUH0 1.000 Q6NUH0 →
Q9M573 1.000 Q9M573 →
Q9GP16 1.000 Q9GP16 →
P0C2H8 1.000 P0C2H8 →
Q9U332 1.000 Q9U332 →
Q7KF90 1.000 Q7KF90 →
Q9SLL7 1.000 Q9SLL7 →
Q9STR1 1.000 Q9STR1 →
Q9V597 1.000 Q9V597 →
Q6FWF4 1.000 Q6FWF4 →
P51420 1.000 P51420 →
Q757D7 0.999 Q757D7 →
A0A1D8PHF5 0.999 A0A1D8PHF5 →
P0C2H9 0.999 P0C2H9 →
Q9URX6 0.999 Q9URX6 →
Q9GN74 0.998 Q9GN74 →
Q9XGL4 0.998 Q9XGL4 →
O65071 0.998 O65071 →
Q9MAV7 0.998 Q9MAV7 →
O18602 0.997 O18602 →
Q54XB5 0.996 Q54XB5 →